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Abstract 
Premature labour is defined as uterine contractions with sufficient intensity, duration and 
frequency to produce progressive cervical effacement and dilatation before 37 weeks of 
gestation (Carson, 2004). It is one of the leading complications in obstetrics. There is 
evidence to suggest that hydrogen sulphide is involved in pregnancy and labour. Research 
has previously shown that H2S can be produced by homogenates of rat and human 
placenta, fetal membranes and pregnant uterus and that H2S donors, L-cysteine and 
sodium hydrosulfide, relax pregnant rat uterine smooth muscle in vitro. The aim of the 
present study was to investigate the production of H2S by isolated cells of the rat placenta, 
fetal membranes and pregnant myometrium in culture. Cell culture techniques were 
performed to disperse Chorio-decidual cells from placenta, amnion/chorion/decidual cells 
from fetal membranes and myometrial smooth muscle. Cells were exposed to 1 mM L-
cysteine for 48 hours and evolved H2S was trapped in 1% zinc acetate solution. The 
resulting sulphide was measured using a standard methylene blue assay and expressed 
as nM H2S produced per min per 105 cells (mean ± SD). The effect of exposing the 
cultured cells from the fetal membranes to 1 μg/ml lipopolysaccharide (LPS) on the 
production of H2S was also investigated. Data were analysed using ANOVA or 
independent samples T test, as appropriate. Rat myometrial smooth muscle cells have a 
H2S mean production rate of 3.63±1.21nM/min/105 cells (n=5), Chorio-decidual cells from 
the placenta have a H2S mean production rate of 45.53± 12.61nM/min/105 cells (n=6) and 
cells from the fetal membranes have a H2S mean production rate of 1.79±0.62nM/min/105 
cells (n=5). Chorio-decidual cells from the placenta had a significantly (P<0.001) higher 
mean production rate of H2S, in comparison to myometrial smooth muscle cells and cells 
from the fetal membranes. The results show that rat chorion, decidual, amnion and 
myometrial smooth muscle cells can produce H2S in culture. Chorio-decidual cells from the 
placenta had the highest production rate of H2S, which could be involved in vasodilation of 
placental blood vessels or maintaining myometrial quiescence. H2S production from 
cultured fetal membrane cells did not increase with the addition of LPS suggesting that 
H2S probably does not act as an inflammatory mediator in this model of intrauterine 
infection. The H2S system requires further research and could be a future target for 
intervention in pregnancy and labour. 
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Chapter One: Introduction 
Human gestation is normally for a period of 37- 42 weeks. The processes in human 
pregnancy from conception to delivery are not fully understood. Implantation of the embryo 
to the uterus wall occurs in the third week of pregnancy. There are various organs within 
the female reproductive system that are involved in pregnancy are: the uterus, the 
placenta, the fetal membranes and the umbilical cord. 
1.1: Human Pregnancy 
 
 
Figure 1.1 Pregnant Human Uterus  
Source: https://my.inova.com/public/healthresearch/content_display_full.cfm?doc_id=P02863 
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The human uterus is a hollow, thick and muscular walled organ found between the urinary 
bladder and the rectum, and it is completely within the pelvis. The anatomical structure of 
the uterus shows that it comprises of the body (including the fundus) and the cervix. The 
fundus is located at the upper part of the body of the uterus connecting it to the ovaries via 
the Fallopian tube. Oocytes are stored in the ovaries and one is usually released every 
month. The oocyte becomes embedded in the uterus wall if it is fertilized.  During 
pregnancy the uterus  changes shape and size to cope with the development of the 
embryo and finally fetus until parturition where it returns almost to its former condition.   
1.2: Human Uterus 
 
The largest part of the uterus is the body. The thick muscular wall of the uterus body 
consists of three layers. The interior layer is the endometrium that functions as a inner 
glandular mucosal lining for the uterus (Prekumar, 2004). It undergoes changes with the 
menstrual cycle. The middle layer is the myometrium which is the muscular structure of the 
uterus wall. It is made up of smooth muscle arranged in longitudinal, oblique and circular 
layers (Prekumar, 2004). The outer layer is the perimetrium which is a thin layer composed 
of mesothelium and connective tissue. The cervix is the narrowing, lower part of the uterus 
which protrudes into the vagina.  
The placenta is an organ fasten to the lining of the womb during pregnancy. It is formed at 
the site of implantation of the embryo in the uterus via the uterine mucosa. It is  a 
hemochorial villous multifunctional organ which is involved in the growth and development 
1.3: Placenta 
FIG.1.2  HAS BEEN REMOVED FOR COPYRIGHT REASONS. 
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of the fetus and it is therefore essential during pregnancy.  It is involved in the exchange of 
gases and nutrients between the maternal and fetal systems and also the elimination of 
waste products from the fetus (Vause and Saroya, 2005). Vause and Saroya (2005) states 
that the placenta is an important site of hormone production. 
Fig. 1.3 OF THE MATURE HUMAN PLACENTA HAS BEEN REMOVED FOR 
COPYRIGHT REASONS. 
The mature human placenta is about 20cm in diameter and 3cm in thickness and is disc 
shaped. The developing embryo (blastocyst) has an outer ectodermal cellular layer called 
the trophoblast and the inner cell mass called the embryoblast. The trophoblast forms the 
interface between the uterine tissues and those of the implanted embryo.  The trophoblast 
quickly differentiates into the syncytiotrophoblast and the cytotrophoblast. The 
syncytiotrophoblast is a multicellular mass while the cytotrophoblast is a mononuclear 
mitotically active layer (Blackburn, 2007). The chorionic villi are formed from the 
cytotrophoblast. This forms the villous system consisting of trabeculae and lacunae 
(vacuoles) which extend through the syncytiotrophoblast. Surrounding this system is the 
primary chorionic plate (towards the embryoblast) and the trophoblastic shell (towards the 
endometrium). Some of the villi are attached to the trophoblastic shell and are called 
anchoring villi. The lacunae system expands continuously to become the intervillous 
space. The maternal circulation is established by cells from the trophoblastic shell which 
move into the maternal endometrial vessels allowing maternal blood to enter. The fetus is 
connected to the placenta via the umbilical cord. It contains two arteries and a vein 
surrounded by a substance which contains collagen, muscle, and mucopolysaccharide 
(Polin et al, 2004). This substance that surronds the umbilical vessel within the umbilical 
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cord is called Wharton’s jelly (Blackburn, 2007). The umbilical cord grows to a maximum 
average length of 55 to 60cm at 30weeks of pregnancy. 
 
 
Page | 13  
 
The fetal membranes are  essential for maintaining pregnancy. They play various roles 
including protecting the fetus against infection, fetal development and progression of 
pregnancy (Gude et al, 2004). The fetus is contained within the fetal membranes until the 
early stages of labour when they rupture . The fetal membranes are  composed of the 
outer membrane which is known as the decidua, the middle membrane known as the 
chorion and the inner layer known as the amnionThe chorion comprises the cellular layer 
consisting of the fibroblast network (thin and present in early prgnancy), recticular layer 
(the major part of the chorion), a pseudo-basement membrane (acting as an anchor for the 
fibroblast) and  the trophoblast cell layer containing 2 to 10 layers of trophoblast cells 
(Bourne, 2006). 
1.4: Fetal Membranes 
The amnion is comprised of five layers, namely the epithelium (in direct contact with the 
amniotic fluid), the compact layer, the fibroblast layer, the intermediate (spongy) layer and 
the basement membrane (connective tissue) (Gude et al, 2004). The amniotic epithelium  
encloses the amniotic fluid. 
Human gestation is normally for a period of 37- 42 weeks. The control of myometrial 
contractility is an important feature of pregnancy and parturition. The myometrium is 
maintained in a relaxed state during pregnancy to accommodate fetal growth; however the 
mechanism underlying uterine quiescence is not fully understood.  
1.5: Uterine Quiescence 
Uterine quiescence also known as myometrial quiescence is the relaxed state of the 
uterus during pregnancy up to labour. Carvajal et al (2009) suggests that quiescence is 
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characterised by profound myometrial insensitivity to agents that normally stimulate the 
uterus. 
 The maintenance of uterine quiescence is not fully understood however it can be 
concluded that it is maintained by a balance of various controlling factors which include 
hormones and substances that suppress the contractility of the myometrium. During labour 
the conditions in the myometrium favour stimulation and less of inhibition. 
Fetal membranes produce one or more factors (e.g. nitric oxide) that act to inhibit 
myometrial contractions and therefore are mediators of quiescence by opening Ca2+ 
activated K+ channels (BKCa) (Carvajal et al, 2006).  
The myometrial cAMP pathway is active during pregnancy and declines significantly as 
labour approaches. According to Carvajal et al (2009) Gαs, a heterotrimeric G-protein is 
the most prominent during pregnancy. Its expression and coupling to adenylate cyclase 
promotes the increased activity of the cAMP pathway and it is said to be increased during 
pregnancy, which maintains myometrial relaxation. The cGMP pathway also increases 
during quiescence and declines before the onset of labour, it also inhibits myometrial 
contraction leading to the suggestion that it is involved in quiescence. 
Nitric oxide, which is produced in intrauterine tissues, has been implicated in uterine 
relaxation. Yallampalli et al (1998) suggested that NO production occurs in parallel to 
changes in expression of NOS II (iNOS). NOS II (iNOS) expression is upregulated by 
progesterone, which also up-regulates the production of NO and increases the relaxant 
effects of NO. A decrease in NO production or its activity may therefore contribute to 
initiation of parturition (Seyffarth et al., 2004). Uterine quiescence during pregnancy and 
increased contractility during labour are maintained partially by the NO system. The NO 
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system interacts with prostaglandins and steroid hormones such as progesterone to 
mediate their effects on uterine contractility. 
 
Labour onset and its progression are controlled by a complex arrangement of many factors 
found in maternal, fetal, and placental tissue. These factors act as signals to either 
maintain a single essential labour-related event and they include prostaglandins, cortisol, 
progesterone and oxytocin. It is known that the onset of labour is an inflammatory event. 
These factors also interact with cytokines in a cascade that has multiple effects. Cytokines 
play a role in the inflammatory process. Steinborn et al (1999) suggested that inflammation 
is linked to spontaneous preterm onset of labour.  
1.6: Mechanism of Human parturition 
The beginning of labour is usually signalled by regular uterine contractions and changes in 
the cervix. The cervix consists of stiff, fibrous tissue during pregnancy in order to retain the 
uterine contents. Prior to delivery the cervix undergoes biochemical changes, termed 
ripening, usually from about the 34th week onwards. The cytokine IL-1 stimulates the 
synthesis of matrix metalloproteinases (MMPs) which are implicated in cervical tissue 
changes associated with labour as well as in the weakening of the membranes in the 
region overlying the cervix prior to rupture (Farinam and Winkelman, 2005). 
With the onset of uterine contractions, white blood cells migrate into the uterine organs 
and release pro-inflammatory cytokines. Pro-inflammatory cytokines are also directly 
produced from labouring uterus, placental and fetal tissues. Changes in the levels of 
cytokines IL-1, IL-6, IL-8 and TNF have been implicated in the onset and progression of 
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pre-term labour. Steinborn et al (1999) stated that cytokines initiate various events which 
include production of prostaglandins, induction of COX2, as well as other factors 
necessary for labour.   
In myometrial contraction, myosin light chain kinase is activated by Ca2+. There is a 
correlation between increased actomyosin ATPase activity, contraction and 
phosphorylation of myosin light chain. The tension development of the smooth muscles in 
the uterus is decreased when myosin light chain phosphorylation is decreased and vice 
versa. 
Myosin has enzymatic activity and is a structural protein which is laid down in thick 
myofilaments. Its enzymatic activity involves the conversion of ATP into motion/force 
generation during contraction. It is composed of two heavy chains of 200,000 KDa each 
and two light chains of about 20,000 and 15,000 KDa. Myosin has a globular head which 
carries three important sites. The first site is the ATPase site where ATP is hydrolyzed. 
The second site is the site where it interacts with actin and the third site is the 20,000 KDa 
light chains which produces the key element of contractile regulation through its 
phosphorylation. Calcium is vital in contractility via the enzyme myosin light chain kinase 
which regulates the phosphorylation and de-phosphorylation of 20,000 KDa light chain of 
myosin enabling the actin and myosin interaction. If myosin light chains are not 
phosphorylated then the interaction between myosin and actin will not occur. 
Oxytocin induces uterine contractions, however it is controversial whether oxytocin in the 
blood or that released locally is important in human labour. 
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Premature labour is defined as uterine contractions with sufficient intensity, duration and 
frequency to produce progressive cervical effacement and dilatation before 37 weeks of 
gestation (Carson, 2004). It is one of the leading complications in obstetrics. In the UK it is 
said to affect 10% of all pregnancy and accounts for 60% of neonatal deaths. It is also the 
said to be the major cause of childhood disability (Gullam et al, 2005).  
1.7: Premature Labour 
The causes of premature labour are being constantly researched yet they remain 
unidentified. There have been multiple factors which have been associated with premature 
labour including fetal development, multiple pregnancies, previous premature deliveries, 
cervical incompetence, the spontaneous rupture of the membranes (PROM) and 
intrauterine infections. Although these factors have a bearing on premature labour it is still 
impossible to predict which women will go into premature or preterm labour. 
The detection of premature labour is an ongoing process however the possibility of 
biochemical and clinical makers are being studied. In hospitals premature labour is 
assessed using clinical criteria (Carbonne, 2004). According to Carbonne (2004) this 
method of clinical assessment of uterine contractions and of cervical changes is highly 
subjective; therefore sensitive methods of detecting patients who are at risk of preterm 
birth are needed to prevent unnecessary treatment or hospital admissions. 
The measurement of electromyography (EMG) is also a means of premature labour 
detection. There are two methods by which uterine EMG can be measured; through the 
uterus using needle electrodes or via abdominal surface electrodes. This method 
measures uterine contractility using electrical activity allowing for evaluation of the state of 
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the uterus for delivery. The measurement of collagen breakdown using light induced 
fluorescence is another technique for detection of premature labour. The cervix contains 
collagen which is fluorescent. Collagen emits light at a typical wavelength of 390 nm. 
During pregnancy (before labour) there is a higher concentration of collagen in the cervix 
and therefore a higher light-induced fluorescence level is measured.  As the cervix ripens, 
before and during labour, the collagen breaks down leading to a lower measurement of 
light-induced fluorescence.  
Fetal fibronectin is a biochemical marker which has been seen to have strong associations 
with premature labour. Fibronectin is an extracellular matrix glycoprotein produced by the 
extravillious cytotrophoblast. It is a “glue-like” protein that bonds the developing baby to 
the uterus. During 22 and 37 weeks of gestation, if the level of fetal fibronectin in 
cervicovaginal secretions is greater than 50ng/ml this indicates a higher risk of preterm 
labour (Petraglia et al, 2007).  The negative predictive value of fibronectin is useful in 
identifying patients who are not at risk for preterm birth. Rizzo et al. (2006) suggests that 
joint use of the fetal fibronectin assay and the ultrasound cervical index improves the 
diagnostic efficiency in preterm labour.  
The prevention and treatment of premature labour is still being researched and remains a 
difficult area. The agents that are used worldwide currently to prevent premature labour 
include β-agonist drugs (ritodrine, terbutaline, salbutamol), oxytocin receptor antagonist 
(atosiban), magnesium sulphate, calcium channel blockers (nifedipine), nitric oxide donors 
and prostaglandin synthesis inhibitors. The β-agonist drugs are used to reduce the 
intensity of preterm labour however their effects last only between 24-48hours (Carson, 
2004). It may be effective for some patients however it has been known to have 
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undesirable side effects. Atosiban is a competitive oxytocin receptor antagonist and it is 
the only oxytocin-antagonist licensed for use in preterm labour. With the inhibition of the 
oxytocin receptor there is a reduction in extracellular calcium influx and release of calcium 
from intracellular stores which leads to inhibition of contractility. Atosiban has fewer side 
effects than β-agonists and is apparently more effective in treating preterm labour (Gullam 
et al, 2005). 
Nifedipine is the most commonly used calcium channel blocker for tocolysis. Calcium 
channel blockers are smooth muscle relaxants which are non-specific and act by inhibiting 
the intracellular influx of calcium ions. There have been varying reports on the side effects 
of nifidipine from no side effects at all to adverse fetal and maternal side effects. 
Magnesium sulphate is a preterm labour management drug used widely but predominantly 
in the United States. It has been met with major opposition in the United Kingdom, Europe 
and Australia as the evidence supporting its use are controversial as it shows no tocolytic 
efficacy. In high doses magnesium sulphate is implicated in possible contribution to infant 
mortality (Pryde et al, 2001). Gasotransmitters are a new look into possible tocolytic 
agents. Nitric oxide has been found to relax uterine smooth muscle contractility. 
Leszczynska-Gorzelak et al, 2001 conducted a clinical trial using nitroglycerine as a donor 
of nitric oxide. It was shown as an effective and safe tocolytic drug, however it is 
suggested that more research needs to be carried out (Leszczynska-Gorzelak et al, 2001).  
Although there are various drugs that seem to have an effect on prevention and treatment 
of preterm labour none of them have high positive results with low side effects. More 
research needs to be done to find tocolytic therapies that are effective in preterm labour 
with reduced side effects allowing for fetal maturity.  
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The mechanism of the onset of Labour within humans is not fully known. However there is 
evidence to suggest that hydrogen sulphide is involved in this process. Hydrogen sulphide 
is a gas signalling molecule. The role of carbon monoxide and nitric oxide as gas signalling 
molecules within mammalian tissue has been extensively researched.  Recently the 
importance of hydrogen sulphide in mammalian tissues as a gas signalling molecule has 
come to light. Although it is still early stages a lot of research is dedicated to better 
understanding the pharmacological, physiological and pathological roles of this gas 
signalling molecule and understanding how it reacts with the other gas signalling 
molecules.  
1.8: Hydrogen Sulphide 
Hydrogen Sulphide is a flammable, colourless gas that is highly present in the 
atmosphere. It is easily noticeable as it has a distinctive rotten-egg smell. H2S is a 
hazardous released from various sources into the atmosphere. For example it is released 
from swamps, marshes, volcanic gases and also during natural gas production and 
sewage treatment. Most of the work done on Hydrogen sulphide has focused on its 
toxicity. In high dosages H2S is lethal. The presence of Hydrogen sulphide has been 
investigated within mammalian tissues. It has been discovered in the brain, smooth 
muscles, vascular tissue, uterus and other tissues. 
H2S production within mammalian tissues is due mainly to two enzymes: cystathionine β 
synthase (CBS) and cystathionine γ Lyase (CSE) using L-cysteine as the main substrate 
(Stipanuk and Beck, 1982). CBS and CSE have been found to be expressed in various 
mammalian tissues. CSE is found in the liver, kidney, small intestine, stomach (Ishii et al 
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2004) and blood vessels (Hosoki et al 1997) while CBS occurs abundantly in the brain 
(Abe and Kimura 1996). 
The first biologically significant role of H2S was discovered in 1996 by Abe and Kimura. 
They discovered high concentrations of H2S in the brain and found that it acts as a 
neuromodulator or neurotransmitter.  In 1997 Hosoki et al. discovered that H2S producing 
enzymes are present in the ileum, portal vein and thoracic aorta suggesting that H2S was 
biologically significant in the tissues. It was concluded that H2S acts smooth muscles as a 
relaxant. In 2001 Zhao et al. concluded that H2S has a cardiovascular effect of relaxation 
and reduces blood pressure in vivo. H2S generation in the pancreas helps to regulate 
insulin release. There is evidence to suggest that H2S acts as an inflammatory mediator. 
H2S is produced in intrauterine tissues (uterus, fetal membranes and human placenta) and 
it acts as a relaxant for pregnant rat uterus. Low levels of H2S were found to cause a dose-
dependent increase in the duration of labour in rats suggesting that it might have an effect 
in pregnancy (Hayden et al., 1990). 
 
It was discovered that H2S is present at relatively high concentrations within the brain (Abe 
and Kimura, 1996) bringing about the conclusion that it has physiological function. H2S – 
producing enzyme cystathionine β–synthase (CBS) is found to be highly expressed in the 
brain specifically the hippocampus and cerebellum. Furthermore it has been observed that 
the concentration of H2S within the brain is in the range of 50 to 160µM. From the 
observations research was done using CBS inhibitors and activators to discover if it was 
1.9: Hydrogen Sulphide as a neuromodulator or neurotransmitter  
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the major mechanism of production of H2S within the brain. The conclusion of this 
research is that CBS is the major H2S –producing enzyme in the brain.  
The roles of H2S in the brain are not yet fully understood but it is involved in modulation of 
synaptic activities regulated by steroids and neurotransmitters. Physiological 
concentrations of H2S induces long-term potential (LTP) at active synapses and this 
requires the activation of NMDA receptors. NMDA receptor antagonist, 2-amino-S-
phosphonovalerate, blocks the LTP previously seen to be induced by NaHS (H2S donor) 
with a weak tetanic stimulation. These observations suggest that H2S functions as a 
neuromodulator activating NMDA receptors. Although this seems to be the main 
mechanism for H2S action research is still ongoing to discover if there are any pathways to 
which H2S acts as a neuromodulator on inactive synapses. 
There are a number of pathways involved in the regulation of H2S in the brain. Ca2+ - and 
calmodulin-mediated pathway are implicated in the regulation of H2S. Ca2+ /calmodulin 
mediate the activity of CBS. Although the actual mechanism of action is unknown it is 
suggest that there is a binding site for Ca2+/calmodulin on CBS which activates it once 
attached. CBS activity is regulated by S-adenosyl-L-methionine (SAM) (Eto et al., 2002). 
The regulation of H2S has been linked to testosterone. There is a difference in the amount 
of H2S in the brain of male mice, which contains more testosterone, in comparison to 
female mice. When male mice are castrated, reducing the testosterone, the amount of H2S 
and SAM reduced. Similarly, when female mice are given an injection of testosterone the 
amount of H2S and SAM are increased. However the difference in H2S between male and 
female mice is much less than the difference in testosterone leading to the conclusion that 
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testosterone only partly regulates H2S. It is suggested that testosterone induces SAM 
which regulates H2S downstream. 
 
Hydrogen Sulphide’s role in inflammation is still in the early stages of research therefore 
not much is known about its role. Li, Bhatia and Moore (2006) suggest that H2S is a 
mediator of inflammation. In acute pancreatitis H2S may be acting as an inducer of 
neurogenic inflammation which support to the role of H2S as an inflammatory mediator. In 
this condition rats treated with D,L-propargylglycine (PAG) had a significant attenuation of 
hyperamylasemia, acinar cell injury/necrosis, pancreatic myeloperoxidase oxidase activity 
and a histological evidence of diminished pancreatic injury. This suggests a reduction in 
the severity of pancreatitis. DL-propargylglycine inhibits CSE and reduces inflammation 
(Bhatia et al., 2005) 
1.10: Hydrogen Sulphide as an inflammatory mediator 
H2S induces the generation of pro-inflammatory cytokines through the upregulation of 
ERK-NF-kB in human monocytes (Zhi et al., 2007). H2S-releasing dithiolthione moiety 
attached to diclofenac is the composition of S-diclofenac phenyl ester. S-diclofenac inhibits 
inflammation in endotoxic shock showing that H2S has an anti-inflammatory effect.  
Addition of NaHS (H2S donor) into peripheral tissue causes an increased sensitivity to pain 
in rat hindpaw. Cystathionine gamma lyase is responsible for endogenous H2S in 
peripheral tissue as inhibition of this enzyme eliminates the hyperalgesia. H2S sensitizes 
T-type Ca2+ channels by its reducing effect leading to hyperalgesia (Kawabata et al, 2007). 
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1.11: Hydrogen Sulphide as a vasorelaxant  
There have been a number of studies done on the role of the H2S as a vasorelaxant. The 
initial research carried out by Hosoki, Matsuki and Kimura (1997) was to discover the 
possible role of H2S on smooth muscle. The H2S-producing enzyme cystathionine γ-lyase 
is expressed in the ileum, portal vein and thoracic aorta and also cystathionine β-synthase 
is expressed ileum only leading to research to measure H2S within these tissues. There is 
a significant amount of H2S found within the tissues suggesting that it has a physiological 
role in the smooth muscle. It was shown that the effect of H2S on smooth muscle within 
these tissues was dose dependent relaxation.  
The vasorelaxant effect of H2S is due to its direct interaction with smooth muscle cells. 
CSE mRNA has been located in vascular smooth muscle cells but not in endothelial layer 
of rat aortic wall (Zhao et al, 2001). The observation that H2S directly interacts with smooth 
muscle cells was reached by Zhao and Wang (2002) based on the fact that H2S still 
relaxed vascular tissues after endothelium removal and also on the failure of removal of 
nerve supply to the tissue to alter H2S effect. Further research has suggested that 
vasorelaxant effect of H2S is endothelium-dependent, contradicting previous notions 
suggesting the opposite, but this dependency is tissue specific. The H2S-induced 
relaxation is significantly reduced in mesenteric artery bed (MAB) when endothelium is 
removed but it is only slightly weakened in rat aortic tissue. 
The H2S relaxation of blood vessels occurs through the opening of KATP channels and the 
H2S–induced vasorelaxation is dependent on extracellular calcium. H2S may reduce the 
extracellular calcium entry and relax tissues. The mechanism for this may be through 
membrane hyperpolarisation occurring when KATP channels open which could close 
voltage-gated Ca2+ channels (Zhao and Wang, 2002). Alternatively there could be a direct 
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interaction between voltage-gated Ca2+ channels in vascular smooth muscle cells and 
H2S. 
However another mechanism for action of H2S relaxation other than its action on KATP 
channels has been discovered. NaHS decreases pHi in a concentration-dependent 
manner in vascular tissue suggesting that endogenous H2S has a role in regulating pHi. In 
vascular smooth muscle a decrease in pHi relaxes vascular vessels. H2S decreases pHi by 
enhancing the activity of an acid loader Cl-/HCO3- exchanger in smooth muscle cells (Lee 
et al., 2007). It is known that intracellular acidification directly stimulates KATP channels 
(Wang et al., 2003). Therefore there may be a relationship between H2S opening of KATP 
channels and its role in decreasing intracellular pH. 
 It has been observed that H2S relaxes the smooth muscle in synergy with nitric oxide 
(Hosoki et al 1997). This observation has been supported by Zhao et al (2001) with the 
discovery that NO donors appear to increase H2S in vascular tissues. This increase is due 
to NO increasing the expression and stimulation of the activity of H2S producing enzyme 
CSE. CSE is stimulated by c-GMP-dependent protein kinase whose activity is increased 
by NO. Blocking c-GMP-dependent protein kinase removes the NO-induced increase in 
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1.12: Hydrogen Sulphide and cardiovascular system 
Research was conducted by Zhao et al (2001) demonstrating the cardiovascular effects of 
H2S. It showed that intravenous injection of H2S provokes a decrease in mean arterial 
blood pressure. The effects of H2S are due to its action on vascular smooth muscle as 
there is no significant change in heart rate. There is a reduction in H2S produced when 
cystathionine gamma-lyase (CSE) is inhibited leading to a reduction in the vasorelaxant 
effect of H2S. This leads to elevated peripheral vascular resistance and increased BP. The 
relaxation occurs through the opening of KATP channels. 
The endogenous production of H2S in the posterior hypothalamus by cystathionine beta-
synthase (CBS) may contribute to central regulation of arterial blood pressure. It was 
shown that infusion of NaHS and the CBS activator; s-adenosyl-l-methionine (SAM), into 
the hypothalamus increases the mean arterial blood pressure while infusion with 
hydroxylamine (HA), a CBS inhibitor, had the opposite effect. KATP channel-dependent 
mechanism seems to mediate this effect (Dawe et al., 2007). 
Recently it has been demonstrated that H2S could contribute to cardio-protection during 
ischemic reperfusion or hypoxia (Geng et al 2004). This could be as a result of mediation 
of KATP channel pathway by H2S produced by heart tissue thereby acting as a 
physiological cardiac function regulator. The cardioprotective effect of H2S also involves 
the preservation of mitochondrial structure and function after ischemia-reperfusion (Elrod 
et al., 2007). It also reduces human vascular smooth muscle cell proliferation by increasing 
the phosphorylation of cardiac extracellular-signal-regulated kinase (ERK) and PI3K/Akt 
pathways. H2S negatively affects the force of muscle contraction and could play a role as a 
regulatory gas signal molecule in the heart (Geng et al., 2004). 
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1.13: Other roles of Hydrogen Sulphide  
H2S-producing enzymes, CBS and CSE, are found in relatively large amounts in the 
pancreatic islets. Pancreatic H2S generation might be involved in the regulation of insulin 
release under physiological conditions. NaHS (H2S donor) and L-cysteine inhibits the 
glucose induced insulin release in pancreatic islets. The levels of endogenous H2S are 
lowered with an increase in extracellular glucose (Yang et al., 2005). H2S regulates KATP 
channels which are known to regulate the function of insulin-secreting pancreatic β cells. 
HS- ion has a pro-survival effect. Rinaldi et al (2006) discovered that HS- ions delay the 
onset of apotosis in polymorphonuclear neutrophils by inhibiting Caspase-3 cleavage and 
p38 MAPK phosphorylation. However, in lymphocytes the effect is the reverse. This pro-
survival activity of HS- ion in neurophils could accelerate the resolution of inflammatory 
processes and prevents the occurrence of new ones. 
NaHS causes strong relaxation in isolated mouse main bronchus but only slightly relaxes 
guinea-pig bronchus. However the mechanism underlying this relaxation is still unclear. It 
has been shown that this relaxation is not induced by K+ATP channels or the NO-cGMP 
pathway. In guinea-pig airways H2S provokes tachykinin-mediated neurogenic 
inflammatory responses. This effect is said to be mediated by the activation of transient 
receptor potential vanilloid 1 (TRPV1) receptors on sensory nerve endings. 
There is a reduction in the vasoconstriction caused by norepinephrine when liver tissue is 
exposed to H2S and L-cysteine. H2S is a physiologically relevant mediator in intrahepatic 
resistance. The hypotensive effect of H2S is mediated through the opening of KATP 
channels which causes the relaxation of resistance blood vessels of the hepatic 
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microcirculation. In liver with cirrhosis there is a reduction in the expression and activity of 
cystathionine gamma lyase leading to a reduction in hepatic H2S production. The 
mechanism of reduction of CSE activity in cirrhosis is unknown however the involvement 
of H2S could help in creating new drugs for the condition. 
L-cysteine and NaHS (a H2S donor) relaxed pregnant rat uterus in vitro (Sidhu et al., 
2001). The expression of CBS and CSE has been detected in rat intrauterine tissues: 
uterus, placenta and fetal membranes. H2S is produced in the intrauterine tissue (rat 
uterus, placenta, fetal membranes and also human placenta) with the addition of L-
cysteine (Patel et al. 2008). The production of H2S in rat fetal membranes is increased by 
nitric oxide. The production of H2S was significantly elevated under hypoxic conditions in 
human placenta, rat liver, uterus and fetal membranes. In fetal membrane, rat uterus and 
human placenta there is an increase in endogenous production of H2S under hypoxic 
conditions. H2S may have a role as an inflammatory mediator in pregnancy and could be 
specifically associated with placental pre-eclampsia (Patel et al, 2008). 
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AIMS 
The aim of this project is to investigate which cells of the rat uterus, placenta and fetal 
membranes produce hydrogen sulphide, from donors, in culture. 
The objectives are to critically review literature relating to hydrogen sulphide production 
and action in the body, to extract cells from the uterus, placenta and fetal membranes of 
pregnant rats and maintain them in culture and measure hydrogen sulphide production by 
these cells in culture. There will also be an investigation into the factors that affect 
hydrogen sulphide production by these cells in culture. 
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Chapter Two: Materials and Methods 
 
Apparatus 
Scalpel, scissors, laminar flow cabinet, beakers, spray bottles, centrifuge tubes, 200 µm 
pore nylon mesh, filter funnel, centrifuge, culture flasks, cell scraper, Pasteur pipettes, auto 
pipettes, sterile tips, Petri dish, lab coat, gloves, trapping tube, test tubes, filter paper. 
 All consumables were obtained from Sigma (Poole, UK). 
  
Chemicals: 
70% Industrial methylated spirit (IMS), VirKon, HAMS F-12, DNase, Trypsin, Collagenase, 
Fetal Bovine Serum, Penicillin Streptomycin (PenStrep), Nystatin, Zinc acetate, N, N-
dimethyl-p-phenyldiamine sulphate, ferric chloride (FeCl3), Sodium hydrosulphide (NaHS), 
Hydrochloric acid (HCl) 
All of the chemicals used were obtained from Sigma-Aldrich (Poole, UK)  
2.1: Cell culture technique 
The pregnant rats at 19 days of gestation were used as a model for human pregnancy. 
The uterus, placenta and fetal membrane were obtained from the rats. The tissues were 
minced into approximately 2mm fragments using sterile scissors and blades. The tissues 
were transferred to sterile centrifuge tubes and digested in 10ml sterile HAMS F-12 
medium containing 0.1% DNAase and 0.1% trypsin for 30minutes at 37oC with shaking. 
0.1% collagenase in HAMS F-12 medium was added and digested for a further 30minutes. 
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The mixture was then filtered through sterile 200 µM pore nylon mesh. The mixture was 
then centrifuged at 500g for 5 minutes. The supernatant was discarded and the pellet was 
re-suspended in 10ml culture medium containing 10% fetal bovine serum, 1% Nystatin and 
2% PenStrep. The resuspended cells were then centrifuged again (called washing) and 
the supernatant removed. The cells were re-suspended in 10 ml complete medium as 
above. A cell count using a haemocytometer slide was performed and also a viability test 
using trypan blue. Trypan blue stains the nuclei of non-viable cells while viable cells 
remained unstained. This staining was seen under the microscope. 
The cell suspensions were placed into a culture flask and incubated for 48 h prior to use, 
so that they could recover from the digestion. After the first incubation the complete 
medium were replaced then 1mM of L-cysteine were added. A tube containing 1% zinc 
acetate was inserted into the flask. The zinc acetate traps any hydrogen sulphide gas 
produced by converting it into zinc sulphide. The cells were incubated for a further 48 
hours. Any zinc sulphide formed in the trapping tube was measured using the standard 
methylene blue assay.  
 
2.2: Methylene blue assay 
The methylene blue assay is a colourimetric assay designed to measure the concentration 
of sulphide ions. Sodium hydrosulphide (NaHS) was used as a H2S donor to produce 
calibration standards. 
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20mM N, N-dimethyl-p-phenyldiamine sulphate was prepared in 7.2M HCl. 30mM ferric 
chloride was prepared in 1.2M HCl. A 10mM stock solution of NaHS was prepared in 50ml 
of distilled water. 
NaHS (10mM) was diluted to 5mM, by taking 500µl of the stock solution and diluting with 
500µl distilled water. The 5mM NaHS solution was then diluted to make a 2.5mM NaHS 
solution, this was continued to produce the calibration standards (as seen in table below) 
Standard concentrations of NaHS (mM) 
Test Tube 0 1 2 3 4 5 6 7 8 9 10 11 
NaHS con. 
(mM) 0 0.005 0.01 0.02 0.039 0.078 0.156 0.313 0.625 1.25 2.5 5 
 
3.5ml of distilled water was added to each calibration standard, followed by 400µl of 20mM 
N, N-dimethyl-p-phenyldiamine sulphate and 400µl 30mM ferric chloride. The calibrators 
were incubated at room temperature for 20minutes and the absorbance was measured at 
670nm on Cecil 1010 spectrophotometer. A calibration curve was produced from the 
results. 
The Methylene blue test involves the reaction of aqueous sulfide with N,N-dimethylphenyl-
1,4-diamine in the presence of a small quantity of ferric ions which gives rise to a 
characteristic blue coloration. Quantification of the amount of Methylene blue formed can 
be easily achieved through UV spectroscopic methods. 
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2.3: Measurement of H2S production in trapping tube 
3.5ml of distilled water was added to the each trapping tube. 400µl of 20mM N, N-
dimethyl-p-phenyldiamine sulphate and 400µl of 30mM ferric chloride was then added. 
The tubes were incubated at room temperature for 20minutes and the absorbance was 
measured at 670nm on Cecil 1010 spectrophotometer. Calibration standards were 
prepared using a 10mM stock solution of NaHS as described previously. A calibration 
curve for the NaHS standards was produced to calculate the concentration of hydrogen 
sulphide. Sulphide concentrations were used to calculate the production rate of hydrogen 
sulphide. 
The baseline production of H2S was investigated in smooth muscle cells from the 
myometrium, chorio-decidual cells from the placenta and amnion/chorion/decidual cells 
from the fetal membranes (n = 5 in each case).  
Amnion cells from the fetal membranes were cultured in the presence of 
lipopolysaccharide (LPS) which will model an intra-uterine infection, and H2S production 










X    X 
     
  X   
     
X    X 
 
Cell count: To get the approximate cell count for the solution we add the cell counts from 
all the cells marked X and Divide it by 5. It was then multiplied by 20,000. 
The concentration of the H2S production is converted to nM per min per 100,000cells. This 
is done by dividing the concentration mM divided the number of minutes in which the H2S 
production is collected multiplied by 1,000,000 (conversion from mM to nM). It is then 
divided by the cell count for each solution. 
= (concentration in mM/minutes) * 1,000,000 
          Cell count/100,000 
 
2.5: Data Analysis 
Using the calibration curves derived from the Methylene blue assay the concentration of 
the H2S production is calculated for each membrane in nM per min 105 cells (mean ± SD). 
Data were analysed using ANOVA or independent samples T test to compare production 
of H2S in the various tissue types and to compare if there is any significant difference 
between the H2S production in fetal membranes exposed to 1 μg/ml lipopolysaccharide 
(LPS).
Haemocytometer slide 
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Chapter three: Results 
After carrying out the cell culture technique as mentioned in the methodology section the 
cell count was calculated. 
CELL COUNT   
Top Left 1 3 
Top Right 0 0 
Middle 0 1 
Bottom left 4 0 
Bottom right 1 0 
Total 6 4 
AVERAGE 5  
Cell count is then calculated as 5/5 * 20,000 = 20,000 per ml 
            = 200,000 per 10ml 
3.1: Validation of Methylene Blue Assay  
Methylene blue assay was validated using the dilution concentrations Table 3.1 below. 
Test Tube 0 1 2 3 4 5 6 7 8 9 
NaHS con. 
(mM) 0 0.005 0.01 0.02 0.039 0.078 0.156 0.313 0.625 1.25 
Table 3.1: The dilution concentrations for calibration curve. 
 
The absorbance of the standard listed in Table 3.1 was measured at 670nm on a Cecil 
1010 spectrophotometer to produce calibration curve.  
Concentration (mM) Absorbance A 
x= y+0.0008 
       1.6566 
0.000 0.000 0 
0.005 0.007 0.004227 
0.010 0.015 0.009058 
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0.020 0.035 0.021135 
0.039 0.054 0.032609 
0.078 0.127 0.076691 
0.156 0.242 0.146135 
0.313 0.548 0.330918 
0.625 1.034 0.624396 
1.250 2.065 1.246981 
Table 3.2: Absorbance of NaHS Calibration standards 
The data recorded from the Methylene blue assay (e.g. Table 3.2) was inputted into an 
excel spreadsheet.  XY Scatter graph was then generated and a Linear Trendline was 
plotted on the graph and the equation for the trendline was generated (e.g. Graph 3.1). 
This Linear regression equation was used to check the proximity in concentration to the 
calibration standards. 
 
The reproducibility of the Methylene blue was checked, the results verified.  
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3.2: The Endogenous Production of H2S 
The endogenous production rate of H2S was calculated from the trapped sulphide 
concentration by using the following formula:   
 
 (Concentration in mM/minutes) * 1,000,000 = Rate of H2S production nM/min/100,000cells 
          Cell count/100,000 
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3.3: Baseline Production of H2S  
The baseline production of H2S was measured in different rat intrauterine tissues with 1 
mM L-cysteine. The baseline production of H2S is shown in tables 3.3, 3.4 and 3.5. 
Date Amplitude (A) Concentration Cell Count 
Conc. in 
nM per min 
Conc. in nM per 
min per 105cells 
22-Feb 0.025 0.015 200,000 5.24 2.62 
29-Feb 4.193 2.175 400,000 755.21 188.80 
06-Mar 4.010 1.883 400,000 653.82 163.45 
11-Mar 0.099 4.344 200,000 1508.33 754.17 
13-Mar 1.181 5.272 400,000 1830.56 457.64 
14-Mar 1.131 5.048 200,000 1752.78 876.39 
17-Mar 1.139 5.024 360,000 1744.44 484.57 
02-Apr 1.141 5.120 240,000 1777.78 740.74 
08-Apr 0.033 0.022 240,000 7.64 3.18 
09-Apr 0.026 0.018 110,000 6.25 5.68 
18-Apr 0.022 0.019 220,000 6.60 3.00 
24-Apr 0.019 0.021 200,000 7.29 3.65 
Table 3.3: The baseline production of H2S in smooth muscle cells from the myometrium. The 
values in red represent the infected cell cultures. 
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Rat myometrial smooth muscle cells have a H2S mean production rate of 
3.63±1.21nM/min/105 cells (n=5) in normal cells and H2S mean production rate of 662.70± 
182.96nM/min/105 cells (n=5) in infected cells. Infected cells had a significantly (P<0.001) 
higher mean production rate of H2S, in comparison normal cells. 
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Date Amplitude (A) Concentration Cell Count Conc. in nM per min 
Conc. in nM per 
min per 105cells 
01-May 1.481 2.012  200,000 698.61 349.31 
30-Apr 0.773 5.360 200,000 1861.11 930.56 
07-May 0.902 9.020 120,000 3131.94 2609.95 
20-May 0.074 0.068  110,000 23.61 21.46 
27-May 0.180 0.148  110,000 62.85 57.13 
28-May 0.203  0.164  110,000 56.94 51.77 
05-Jun 1.758 2.738 110,000 950.69 864.27 
11-Jun 0.180 0.161  110,000 55.90 50.82 
14-Jul 0.221 0.168  120,000 58.33 48.61 
28-Jul 0.202 0.137  110,000 47.71 43.37 
16-Jun 0.852 5.960 400,000 2069.44 517.36 
18-Jun 0.845 5.900 300,000 2048.61 682.87 
Table 3.4: The baseline production of H2S in chorio-decidual cells from the placenta 
membrane. The values in red represent the infected cell cultures. 
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Chorio-decidual cells from the placenta have a H2S mean production rate of 45.53± 
12.61nM/min/105 cells (n=6) in normal cells and H2S mean production rate of 782.22± 
342.59nM/min/105 cells (n=5) in infected cells. Infected cells had a significantly (P<0.001) 
higher mean production rate of H2S, in comparison normal cells. 
Date Amplitude (A) Concentration Cell Count 
Conc. in 
nM per min 
Conc. in nM per 
min per 105cells 
09-May 0.026 0.030 800,000 10.42 1.30 
27-May 0.007 0.025 800,000 8.68 1.09 
28-May 0.502 0.503 600,000 174.65 29.11 
05-Jun 1.256 1.970 800,000 684.03 85.50 
06-Jun 0.583 0.469 600,000 162.85 27.14 
09-Jul 0.025 0.044 800,000 15.28 1.91 
28-Jul 0.038 0.046 800,000 15.97 2.00 
29-Jul 0.091 0.061 800,000 21.18 2.65 
Table 3.5: The baseline production of H2S in amnion/chorion/decidual cells from the fetal 
membranes. The values in red represent the infected cell cultures. 
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Fetal membranes have a H2S mean production rate in normal cells of 
1.79±0.62nM/min/105 cells (n=5) and H2S mean production rate in infected cells of 
37.11±19.15nM/min/105 cells (n=3). Infected cells had a significantly (P<0.001) higher 
mean production rate of H2S, in comparison normal cells. 
 
Rat myometrial smooth muscle cells have a H2S mean production rate of 
3.63±1.21nM/min/105 cells (n=5), Chorio-decidual cells from the placenta have a H2S 
mean production rate of 45.53± 12.61nM/min/105 cells (n=6) and cells from the fetal 
membranes have a H2S mean production rate of 1.79±0.62nM/min/105 cells (n=5). The 
tissue collection was from different rats. Chorio-decidual cells from the placenta had a 
significantly (P<0.01) higher mean production rate of H2S, in comparison to myometrial 
smooth muscle cells and cells from the fetal membranes. 
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Concentration Cell Count Concentration 
(nM per min) 
Concentration 
(nM per min per 
105cells) 
 
0.034 0.034 100,000 11.80 11.80  
0.029 0.032 100,000 10.96 10.96 +LPS 
0.073 0.055 280,000 19.16 6.84  
0.051 0.043 280,000 15.06 5.38 +LPS 
0.035 0.029 150,000 9.94 6.62  
0.048 0.037 150,000 12.69 8.46 +LPS 
0.045 0.035 160,000 12.14 7.59  
0.040 0.032 160,000 11.04 6.90 +LPS 
Table 3.6 Represents the baseline production of H2S in amnion/chorion/decidual cells 
from the fetal membranes with and without LPS. 
     
 
Statistical analysis (T-Test) shows that there is no significant difference in H2S production 
with the addition of lipopolysaccharide (control: 8.21±2.42 versus LPS treated: 
7.92±2.38nM/min/105 cells; n=4). 
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Chapter Four: Discussion 
Human pregnancy and labour are complicated processes and to-date there are no definite 
answers to how the uterus is maintained in a quiescent state or how labour is initiated. 
There are however a number of factors that have been found to influence the maintenance 
of pregnancy and initiation of labour. Premature labour is a major complication affecting 
pregnancy. Premature labour has been associated with multiple factors including fetal 
development, multiple pregnancies, previous premature deliveries, obesity, cervical 
incompetence, the spontaneous rupture of the membranes (PROM) and intrauterine 
infections (Behrman et al, 2007).  
It has previously been shown that H2S is produced by homogenates of rat uterus, 
placenta, fetal membranes and human placenta (Patel et al., 2009), however the exact 
cellular source was not known. CBS and CSE enzymes have been found widely in female 
reproductive tissues especially in human myometrium, amnion, chorion and placenta.  This 
suggests that they do have some functional role in reproduction. The exact location of the 
CBS and CSE enzymes in these tissues is unknown as there are no published data on 
immunohistochemical staining of sections of reproductive tissues. One reason for this is 
that the early available antibodies to CBS and CSE did not work for immunohistochemistry 
applications. There are now much better antibodies available commercially, so hopefully 
this important gap in the knowledge will be filled soon. 
 The aim of the current study was to extract cells from the uterus, placenta and fetal 
membranes of pregnant rats and maintain them in culture and measure hydrogen sulphide 
production by these discrete cells in culture. A secondary aim was to investigate factors 
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that may influence the production of hydrogen sulphide in order to determine possible 
roles of hydrogen sulphide during pregnancy. 
The cell isolation and cell culture technique, involves the use of digesting/ dissociating 
enzymes to break down the connective tissue that hold the cells together. It is a common 
technique and for this research the enzymes used were trypsin, DNAse and collagenase. 
The cell culture technique is an aseptic technique and care was taken to maintain this at 
all times. However, there was a problem with a persistent infective agent in the cell 
cultures which eluded identification, despite the use of penicillin and streptomycin. The 
capture and measurement of H2S production was adapted from Patel et al (2009). The 
methylene blue assay was used to measure endogenous production of H2S. The assay 
was reproducible and gave linearity (R2) of > 0.98. 
Patel et al (2009) has shown that H2S is produced in homogenised rat fetal membrane, 
placenta and uterus and human placenta. It was shown that CBS and CSE are present in 
human myometrium, amnion, chorion and placenta. Homogenates did not give a definite 
identity to the source of H2S production as it has been shown that CSE is expressed in the 
walls of blood vessels and so any large blood vessels in the tissue sample could be a 
source of CSE. The current research was therefore done using primary cell culture 
incubations of myometrial smooth muscle cells, chorio-decidual cells from the placenta 
and amnion/chorion/decidual cells from fetal membranes from pregnant rats.  This showed 
that rat chorion, decidual, amnion and myometrial smooth muscle cells can produce H2S in 
culture. It is difficult to compare the results from this publication with the current study. In 
Patel et al (2009) H2S production was measured in nM/min/g however in this research H2S 
production was measured in nM/min/105cells.  
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The highest production rate of H2S was from chorion-decidual cells from the placenta. The 
mean production rate of these cells was 45.53±12.61nM/min/105cells (n=6). The placenta 
is a highly metabolic organ which produces many hormones and this could be the reason 
for the high production rate. The high production rate may also be related to its possible 
function in maintaining pregnancy. It is possible that the H2S produced in placenta 
circulates into surrounding tissues causing vasodilation of placental blood vessels or 
maintaining myometrial quiescence. Research shows that H2S is a vasodilator and is 
involved in the regulation of blood pressure (Wang, 2008). H2S could be involved in the 
local control of blood flow, particularly in the placenta; however this still has to be 
researched further as there are currently no published studies in this area using human 
placental blood vessels.   
There has been previous research done by Hayden et al, (1990) showing that H2S 
administered externally prolongs the duration of delivery in rats. Sidhu et al (2001) also 
showed that L-cysteine relaxes pregnant rat uterus in vitro. This means that H2S could act 
locally in myometrial smooth muscle cells thereby maintaining uterine quiescence. H2S 
donors have been shown to inhibit spontaneous uterine contractions in rats in vitro (Sidhu 
et al., 2008). So far, there are no data on effects on human myometrium. Uterine 
contractions could be inhibited by an upregulation of CBS and CSE in pregnancy which 
causes production of H2S in the myometrium and placenta. 
H2S may have a role as an inflammatory mediator in the reproductive system however this 
role is still unclear. There is good evidence that the initiation of parturition in humans 
involves inflammation (Norman et al, 2007). Various studies have shown that nitric oxide 
has a function as an inflammatory mediator, particularly in the cervix at term (Norman et al, 
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2007). Previous studies have shown that intrauterine infections may be a risk factor in 
premature labour. It is suggested that premature labour is caused by the activation of the 
innate immune system and inflammation triggered by intrauterine bacteria. 
Lipopolysaccharide (LPS) is a lipid and polysaccharide joined by a covalent bond. It is a 
major component found on the outer cell wall of certain bacteria. The presence of LPS 
triggers an innate immune response to infection. LPS mimics the presence of bacteria, 
therefore the addition of LPS in fetal membrane culture mimics possible intrauterine 
infection. However, in this study there was no significant difference between H2S 
production rate in the fetal membrane cells with the addition of lipopolysaccharide. This 
means that H2S production does not increase when there is a bacterial infection in the fetal 
membrane. Therefore increased H2S production does not appear to act as an 
inflammatory mediator in the fetal membranes, whereas this was found to be the case for 
nitric oxide (Seyffarth et al., 2004). .  
In the process of this research there were various complications with infections in the cell 
cultures. The infection was prevalent even though Penicillin Streptomycin (PenStrep) and 
Nystatin where used. The measurement of H2S production was still calculated even for the 
cell cultures that appeared infected. The H2S production of the infected culture where 
compared with those of non-infected culture and there was a significant difference. The 
H2S production in the infected cell culture was higher than that of the non-infected culture. 
The higher rate of H2S production by the infected cells could be due to the infecting agent 
triggering more production from the uterine cells, whereas LPS alone did not do this. 
However it is also possible that the infective agent could breakdown L-cysteine to produce 
the H2S directly. In laboratory conditions where LPS was used the outcome was that there 
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was no significant increase in the production of H2S from the fetal membrane cells, 
however in the cases of the infected cells the production was significantly higher, this 
means that the most likely explanation is that the infective agent was breaking down the L-
cysteine to give H2S. More controlled research will need to be carried out to determine the 
actual role of bacterial infections on H2S production in the intrauterine cells.  
Although it has been stated that H2S could be involved in reproduction however one 
research has shown that this may not be accurate as CSE -/- knockout mice are fertile and 
give birth normally (Wang et al, 2008). However this may not be the same for human as it 
is possible that there are differences in species.  
Srilatha et al (2009) has shown that H2S relaxes the smooth muscle partially via cAMP, 




Further work must be done to understand the production of H2S from intrauterine tissues. 
It is important to investigate the enzymes that are involved in this production. 
Immunohistochemical staining, Western blotting and RT-PCR for mRNA for both CBS and 
CSE enzymes need to be carried out. Completing these research will assist to determine 
the location of production of H2S and possible roles. Research also needs to be carried out 
to investigate factors which affect the expression of CBS and CSE. 
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The diagram above is a model of the production of hydrogen sulphide from myometrial 
smooth muscle cells, chorio-decidual cells from the placenta and amnion/chorion/decidual 
cells from fetal membranes of pregnant intrauterine tissues and its possible roles. The 
model shows that hydrogen sulphide produced in chorion-decidual cells of placenta and 
myometrial smooth muscle cells could be involved in maintaining myometrial quiescence. 
The function of H2S produced in amnion/chorion/decidual cells of the fetal membranes is 
not yet known.  
 
In conclusion this research has shown that myometrial smooth muscle cells, chorio-
decidual cells from the placenta and amnion/chorion/decidual cells from fetal membranes 


































Figure 5.1 shows a model of the possible roles of H2S in the female 
reproductive tract in pregnancy. 
L- cysteine −−−− →H2S 
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uterine quiescence and vasodilation leading to regulation of local blood flow.  However this 
research was done using rat uterus, placenta and fetal membrane. It is therefore 
necessary to repeat the research using human uterus, placenta and fetal membrane as 
there might be species-dependent differences in the result. It is then essential that further 
research is carried out to confirm/determine the role of H2S within the intrauterine tissue 
and the mechanisms.  
Despite several interventions designed to inhibit preterm labour and prolong pregnancy, 
the frequency of preterm birth is still a great problem worldwide. If the roles of H2S within 
pregnancy are established it may prove to be a way forward in preventing and/or treating 
premature labour. 
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